Maravai Lifesciences Holdings (MRVI) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q4 2024 value amounting to $28.9 million.
- Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization rose 48992.32% to $28.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.9 million, marking a year-over-year increase of 48992.32%. This contributed to the annual value of $28.9 million for FY2024, which is 48992.32% up from last year.
- Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization amounted to $28.9 million in Q4 2024, which was up 48992.32% from -$7.4 million recorded in Q4 2023.
- Maravai Lifesciences Holdings' 5-year Accumulated Depreciation & Amortization high stood at $28.9 million for Q4 2024, and its period low was -$9.7 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $5.6 million (2021), whereas its average is $4.7 million.
- Per our database at Business Quant, Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization tumbled by 21760.14% in 2023 and then skyrocketed by 48992.32% in 2024.
- Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Accumulated Depreciation & Amortization stood at -$9.7 million in 2020, then soared by 157.64% to $5.6 million in 2021, then grew by 12.55% to $6.3 million in 2022, then plummeted by 217.6% to -$7.4 million in 2023, then skyrocketed by 489.92% to $28.9 million in 2024.
- Its Accumulated Depreciation & Amortization was $28.9 million in Q4 2024, compared to -$7.4 million in Q4 2023 and $6.3 million in Q4 2022.